GOOFICE®

Product Sheet

  • Image of tablet in Japan as of August, 2021.
    Image of tablet in Japan as of August, 2021.
  • Image of PTP sheet (front side) in Japan as of August, 2021.
    Image of PTP sheet (front side) in Japan as of August, 2021.
  • Image of PTP sheet (back side) in Japan as of August, 2021.
    Image of PTP sheet (back side) in Japan as of August, 2021.

(zip JPEG file:374KB)

Product Name GOOFICE®
Drug Class Name Ileal Bile Acid Transporter Inhibitor
Category Prescription Drug
Storage Store at temperature below 30℃
(Store protected from high temperature and moisture after opening the aluminum pouch.)
Expiration Date 36 months
Approved Countries and Regions Japan
Thailand
Philippines
Indonesia
(As of June 2023)
Dosage Form Tablet

 

Product Information

Clinical Study

Product Video

GOOFICE® Mechanism of Action

Created in December, 2022

04:58

GOOFICE® is the world’s first drug that inhibits the ileal bile acid transporter ( IBAT ).

Q&A

  • Q. GOOFICE® is administered before meals. Why is it?

    A.

    It is to efficiently inhibit bile acid reabsorption in the intestine.
    This drug directly inhibits the transporter involved in bile acid reabsorption (IBAT) in the terminal ileum1 (it does not move into blood to exert its effect), and inhibits reabsorption of bile acids,2 thereby increasing the flow of bile acids into the large intestine.
    For this reason, it seems desirable for efficient onset of effects that this drug is administered before bile acids are released into the duodenum following stimulation with food.

    Since there is a report from healthy individuals (n=5)3 showing that bile acids are secreted under stimulation by breakfast, lunch, and dinner, it is considered that similar effects are exerted when the drug is administered before breakfast, lunch, and dinner, and the timing of administration of this drug is set to be administration before meals.

    Circadian variation in serum bile acid concentration by background

    Circadian variation in serum bile acid concentration by background

    【Reference】
    1) EA Pharma Co., Ltd.: In-house data (effect on bile acid transporters)
    2) EA Pharma Co., Ltd.: In-house data (effect on bile acid absorption)
    3) Schalm SW, et al. Gut 1978; 19: 1006-14

    Prepared in November 2018

  • Q. Is it acceptable to take GOOFICE® immediately before meals, after meals, between meals, at bedtime, or as needed?

    A.

    The approved dosage regimen of this drug is "oral administration once daily before meals." Administration with other dosage regimens is outside the approved dosage regimen, and there are no data on the efficacy and safety of this drug taken immediately before meals, after meals, between meals, at bedtime, or as needed.

    For efficient onset of the effects of this drug, it is desirable to administer this drug before bile acids are released into the duodenum after stimulation with meals, that is, "before meals." Therefore, the dosage regimen is specified as "administration before meals."
    The only investigation performed with the dosage regimen other than "once-daily oral administration before meals" was the investigation of the safety, pharmacokinetics, and effects of meals in the crossover study (Japanese phase 1 study)1 of single-dose administration under fasting conditions and single-dose administration before breakfast in Japanese patients with chronic constipation.

    Excerpt from the package insert
    [Dosage and Administration]
    The usual adult dose is 10 mg of elobixibat administered orally once daily before meals. The dose may be adjusted appropriately according to symptoms; however, the maximum daily dose is 15 mg.

    Reference:
    In clinical studies for development, the drug was administered approximately 30 minutes before breakfast.

    【Reference】
    1) EA Pharma Co., Ltd.: In-house data (clinical pharmacology study in patients with chronic constipation)

    Prepared in November 2018

  • Q. While GOOFICE® is to be administered before meals, which is the best timing, before breakfast, before lunch, or before dinner? Are there any data on comparisons?

    A.

    The approved dosage regimen of this drug is “The usual adult dose is 10 mg of elobixibat administered orally once daily before meals. The dose may be adjusted appropriately according to symptoms; however, the maximum daily dose is 15 mg.” Therefore, the drug can be taken either before breakfast, before lunch, or before dinner.
    Since there is a report from healthy individuals (n=5)1 showing that bile acids are secreted under stimulation by breakfast, lunch, and dinner, it is considered that similar effects are exerted when the drug is administered before breakfast, lunch, and dinner.

    Therefore, set a time before breakfast, lunch, or dinner considering the patient's dosing compliance, and take the drug at that time.
    Because the Japanese phase 2 study, Japanese phase 3 study, and Japanese long-term administration study were all conducted with “administration before breakfast,” there are no data on the evaluation of differences in efficacy and safety among administration before breakfast, lunch, and dinner.

    Circadian variation in serum bile acid concentration by background

    Circadian variation in serum bile acid concentration by background

    【Reference】
    1) Schalm SW, et al. Gut 1978; 19: 1006-14

    Prepared in November 2018

Partners

Thailand

Eisai (Thailand) Marketing Co.,Ltd.
6th Floor, GPF Witthayu Tower A,
93/1 Wireless Road, Pathumwan, Bangkok 10330, Thailand

Philippines

Hi-EISAI PHARMACEUTICAL, INC.
Unit2, 22F, Tower 6789
6789 Ayala Avenue, Makati City 1226 Philippines

Indonesia

PT Eisai Indonesia
Agro Plaza 14th Floor
Jl. H.R Rasuna Said Kav X-2 No.1
Jakarta - 12950, Indonesia

You are now leaving the EA Pharma website.

Thank you for browsing the EA Pharma website.
You are about to visit an external website.
(A new browsing window will be opened)

Click here to proceed

The Section is for Medical Professionals.

Terms of Use

The purpose of the section is to provide useful information to medical professionals (doctors, dentists, pharmacists, nurses, nutritionists, care workers, etc.) working in medical institutions.
Please note that the section is not intended to provide information to medical professionals outside of the approved countries, nor to the general public.

Doctor, Nurse, Pharmacist, Other Medical Professionals

If you are not a medical professional